ketanserin - CISMeF

Preferred Label : ketanserin;

MeSH definition : A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.;

MeSH synonym : 3-(2-(4-(4-fluorobenzoyl)piperidinol)ethyl)-2,4(1h,3h)-quinazolinedione;

MeSH hyponym : R-41,468; R 41,468; R41,468; R-41468; R 41468; R41468;

MeSH CAS label : 2,4(1H,3H)-Quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-;

MeSH Related Number : 74050-98-9 (Ketanserin);

Registry Number MeSH : 74050-98-9;

Wikipedia link : https://en.wikipedia.org/wiki/Ketanserin;

Codes EINECS : 277-680-2;

Is substance : O;

UNII : 97F9DE4CT4;

InChIKey : FPCCSQOGAWCVBH-UHFFFAOYSA-N;

Détails

Origin ID

D007650;

UMLS CUI

C0022616;

ATC code(s)
- ketanserin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Ketanserin [ICD-11 Extension code]
CISMeF manual mappings
- ketanserin [Substance BNPC]
Pharmacological action(s)
- antihypertensive agents [MeSH Descriptor]
- platelet aggregation inhibitors [MeSH Descriptor]
- serotonin antagonists [MeSH Descriptor]
Record concept(s)
- R-41,468 [MeSH concept]
- ketanserin [MeSH concept]
Related MeSH Supplementary Concept(s)
- 6-azidoketanserin [MeSH Supplementary Concept]
- 6-hydroxyketanserin [MeSH Supplementary Concept]
- 7-amino-8-iodoketanserin [MeSH Supplementary Concept]
- 7-aminoketanserin [MeSH Supplementary Concept]
- 7-azidoketanserin [MeSH Supplementary Concept]
- N-2-fluoroethylketanserin [MeSH Supplementary Concept]
- Poly-5 [MeSH Supplementary Concept]
- altanserin [MeSH Supplementary Concept]
- azidoiodoketanserin [MeSH Supplementary Concept]
- butanserin [MeSH Supplementary Concept]
- ketanserinol [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing ketanserin (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Ketanserin [NCIt concept]
- Ketanserin (substance) [SNOMED CT concept]
- Product containing ketanserin (medicinal product) [SNOMED CT concept]
- ketanserin [ATC Code]
- ketanserin [Substance BNPC]
Validated automatic mappings to BTNT
- ketanserin [ATC Code]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients